Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD.

Benucci, Maurizio; Damiani, Arianna; Giannasi, Gianfranco; Li Gobbi, Francesca; Quartuccio, Luca; Grossi, Valentina; Infantino, Maria; Manfredi, Mariangela

Benucci, Maurizio; Damiani, Arianna; Giannasi, Gianfranco; Li Gobbi, Francesca; Quartuccio, Luca; Grossi, Valentina; Infantino, Maria; Manfredi, Mariangela.

Benucci M; Rheumatology Unit, S Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy maubenucci@tiscali.it.
Damiani A; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
Giannasi G; Emergency Department and Covid Unit, S Giovanni di DioHospital, Azienda USL-Toscana Centro, Florence, Italy.
Li Gobbi F; Rheumatology Unit, S Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.
Quartuccio L; Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, Udine, Italy.
Grossi V; Immunology and Allergology Laboratory, S.Giovanni di DioHospital, Azienda USL-Toscana Centro, Florence, Italy.
Infantino M; Immunology and Allergology Laboratory, S.Giovanni di DioHospital, Azienda USL-Toscana Centro, Florence, Italy.
Manfredi M; Immunology and Allergology Laboratory, S.Giovanni di DioHospital, Azienda USL-Toscana Centro, Florence, Italy.

Ann Rheum Dis ; 2020 Jul 06.

Article in English | MEDLINE | ID: covidwho-2251869

Keywords

biological therapy; epidemiology; health services research

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-218214

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google